Efficacy and safety of alirocumab in people with prediabetes vs those with normoglycaemia at baseline: a pooled analysis of 10 phase III ODYSSEY clinical trials
Leiter, L. A., Müller‐Wieland, D., Baccara‐Dinet, M. T., Letierce, A., Samuel, R., Cariou, B.
Published in Diabetic medicine (01.01.2018)
Published in Diabetic medicine (01.01.2018)
Get full text
Journal Article
Increased insulin sensitivity and basal insulin effectiveness in postprandial reactive hypoglycaemia
Brun, J F, Bouix, O, Monnier, J F, Blachon, C, Jourdan, N, Baccara, M T, Fédou, C, Orsetti, A
Published in Acta diabetologica (01.03.1996)
Published in Acta diabetologica (01.03.1996)
Get more information
Journal Article
4115Effect of alirocumab on recurrent cardiovascular events after acute coronary syndrome, according to the intensity of background statin treatment
Diaz, R, Li, Q H, Bhatt, D L, Bittner, V A, Baccara-Dinet, M T, Goodman, S G, Jukema, J W, Parkhomenko, A, Pordy, R, Reiner, Z, Szarek, M, Tse, H F, Zeiher, A M, Schwartz, G G, Steg, P G
Published in European heart journal (01.10.2019)
Published in European heart journal (01.10.2019)
Get full text
Journal Article
4114Efficacy of alirocumab treatment after acute coronary syndrome according to new ACC/AHA guidelines for lipid-lowering therapy
Roe, M T, Szarek, M, Li, Q H, Bhatt, D L, Bittner, V, Goodman, S G, Harrington, R A, Lopez-Jaramillo, P, Lopes, R D, Louie, M J, Moriarty, P M, Vogel, R A, Baccara-Dinet, M T, Steg, P G, Schwartz, G G
Published in European heart journal (01.10.2019)
Published in European heart journal (01.10.2019)
Get full text
Journal Article
Efficacy and safety of alirocumab vs ezetimibe in statin-intolerant patients, with a statin rechallenge arm: The ODYSSEY ALTERNATIVE randomized trial
Moriarty, Patrick M., MD, Thompson, Paul D., MD, Cannon, Christopher P., MD, Guyton, John R., MD, Bergeron, Jean, MD, Zieve, Franklin J., MD, PhD, Bruckert, Eric, MD, Jacobson, Terry A., MD, Kopecky, Stephen L., MD, Baccara-Dinet, Marie T., MD, Du, Yunling, PhD, Pordy, Robert, MD, Gipe, Daniel A., MD
Published in Journal of clinical lipidology (01.11.2015)
Published in Journal of clinical lipidology (01.11.2015)
Get full text
Journal Article
Efficacy and safety of alirocumab, a monoclonal antibody to PCSK9, in statin-intolerant patients: Design and rationale of ODYSSEY ALTERNATIVE, a randomized phase 3 trial
Moriarty, Patrick M., MD, Jacobson, Terry A., MD, Bruckert, Eric, MD, Thompson, Paul D., MD, Guyton, John R., MD, Baccara-Dinet, Marie T., MD, Gipe, Daniel, MD
Published in Journal of clinical lipidology (01.11.2014)
Published in Journal of clinical lipidology (01.11.2014)
Get full text
Journal Article
Efficacy and safety of the proprotein convertase subtilisin/kexin type 9 monoclonal antibody alirocumab vs placebo in patients with heterozygous familial hypercholesterolemia
Kastelein, John J.P., MD, PhD, FESC, Hovingh, G. Kees, MD, PhD, Langslet, Gisle, MD, Baccara-Dinet, Marie T., MD, Gipe, Daniel A., MD, Chaudhari, Umesh, MD, Zhao, Jian, MS, Minini, Pascal, PhD, Farnier, Michel, MD, PhD
Published in Journal of clinical lipidology (01.01.2017)
Published in Journal of clinical lipidology (01.01.2017)
Get full text
Journal Article